Who Paid My Doc
Jeffrey Bazarian
Physical Medicine & Rehabilitation Rochester, NY Medical Doctor
NPI 1063430239 CMS profile 1133756
4901 Lac De Ville Blvd, Suite 250, Rochester, NY 14618
General payments
$46,640
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$383,280
Through program year 2024, Jeffrey Bazarian of Rochester, NY is reported in the CMS Open Payments database as having received $46,640 across 21 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $383,280 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $10,886 | 4 | |
| 2023 | General | $15,440 | 4 | |
| 2021 | General | $13,041 | 6 | |
| 2020 | General | $5,145 | 4 | |
| 2019 | General | $2,127 | 3 |
Beside peers
- Jeffrey Bazarian
- Physical Medicine & Rehabilitation median
- Middle half of Physical Medicine & Rehabilitation
- National median
In program year 2025, general payments to Jeffrey Bazarian were reported at $0. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.
Show as a table
| Year | Jeffrey Bazarian | Physical Medicine & Rehabilitation median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $2,127 | $133 | $45–$390 | $163 |
| 2020 | $5,145 | $88 | $29–$272 | $114 |
| 2021 | $13,041 | $116 | $33–$360 | $132 |
| 2022 | $0 | $123 | $40–$378 | $149 |
| 2023 | $15,440 | $131 | $43–$396 | $160 |
| 2024 | $10,886 | $141 | $45–$409 | $164 |
| 2025 | $0 | $139 | $48–$410 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
21 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physical Medicine & Rehabilitation in New York
Heidi Fusco
Physical Medicine & Rehabilitation · New York, NY
Geraldine Dapul
Physical Medicine & Rehabilitation · Rochester, NY
Michael Odell
Physical Medicine & Rehabilitation · New York, NY
Craig Antell
Physical Medicine & Rehabilitation · New York, NY
Michael Stubblefield
Physical Medicine & Rehabilitation · New York, NY
Heakyung Kim
Physical Medicine & Rehabilitation · New York, NY
Related records
Physical Medicine & Rehabilitation in New York
Practitioners in the same specialty and state, ranked by reported value.
All Physical Medicine & Rehabilitation
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.